Aurinia Pharmaceuticals (AUPH) Enterprise Value Growth (1y) (2017 - 2026)
Aurinia Pharmaceuticals (AUPH) Enterprise Value Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Aurinia Pharmaceuticals |
2.18 Bn |
1.80 Bn |
71.20 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-21.06% |
| Dec 31, 2025 |
-11.02% |
| Sep 30, 2025 |
-0.88% |
| Jun 30, 2025 |
4.64% |
| Mar 31, 2025 |
2.19% |
| Dec 31, 2024 |
-2.28% |
| Sep 30, 2024 |
-3.21% |
| Jun 30, 2024 |
5.77% |
| Mar 31, 2024 |
11.51% |
| Dec 31, 2023 |
9.99% |
| Sep 30, 2023 |
10.29% |
| Jun 30, 2023 |
10.47% |
| Mar 31, 2023 |
13.66% |
| Dec 31, 2022 |
16.45% |
| Sep 30, 2022 |
-31.51% |
| Jun 30, 2022 |
-22.89% |
| Mar 31, 2022 |
-20.23% |
| Dec 31, 2021 |
-17.01% |
| Dec 31, 2020 |
-30.16% |
| Dec 31, 2019 |
-143.15% |
